Shëndeti

BioNTech founder Ugur Sahin: I am confident that next year we will have a normal winter

BioNTech founder Ugur Sahin: I am confident that next year we will have a normal

The impact of a new Covid vaccine will be seen over the summer and life is expected to return to normal by next winter, said one of its creators.

Professor Ugur Sahin, co-founder of BioNTech, said this winter will still be difficult as the vaccine will not have a major impact on the number of infections.

In an interview on the BBC's Andrea Marr Show, Sahin said he was convinced the vaccine would reduce transmission between people, as well as stop the development of symptoms in someone who has been vaccinated.

"It is possible that the vaccine could halve the transmission, which would have a major impact. "I am very confident that human transmission will be reduced by such an effective vaccine, maybe not 90%, but maybe 50%, but we must not forget that this too can result in a dramatic reduction in the spread of the pandemic." he said.

After the announcement of the world’s first effective vaccine, John Bell, a professor of medicine at Oxford University, suggested that life could return to normal by spring.

BioNTech founder Ugur Sahin: I am confident that next year we will have a normal

"I'm probably the first person to say that, but I'll say it with some confidence," he said.

However, Professor Sahin said it would take more time:

"If all goes well, the vaccine will start being distributed later this year, early next year."

Sipas tij, qëllimi është që të jepeshin më shumë se 300 milionë doza në të gjithë botën deri në prillin e ardhshëm, që sipas tij është vetëm fillimi i një impakti.

BioNTech founder Ugur Sahin: I am confident that next year we will have a normal

Ai tha se ndikimi më i madh do të ndodhte më vonë: "Vera do të na ndihmojë sepse shkalla e infeksionit do të ulet në verë dhe ajo që është absolutisht thelbësore është që ne të marrim një normë të lartë vaksinimi deri ose para vjeshtës / dimrit të vitit të ardhshëm".

Profesor Sahin tha se është thelbësore që të gjitha programet e imunizimit të përfundojnë para vjeshtës së ardhshme.

Javën e kaluar, BioNTech dhe bashkë-zhvilluesi Pfizer thanë se analiza paraprake tregoi se vaksina e tyre mund të parandalonte më shumë se 90% të njerëzve të preken nga Covid-19. Rreth 43,000 njerëz morën pjesë në teste.

Elderly and nursing home staff are likely to have priority, followed by health workers. People will then be given priority according to age./ BBC source

* It is forbidden to republish the article without the source Tiranapost.al